Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis

Lupus

Volumn 17, Issue 10, 2008, Pages 916-921

  Chen, Pojen P ^a   Yang, C D ^b   Ede, K ^a   Wu, C C ^a   FitzGerald, J D ^a   Grossman, J M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antiphospholipid antibodies; Coagulation; Fibrinolysis; Serine protease

Indexed keywords

ACTIVATED PROTEIN C; AUTOANTIBODY; AUTOANTIGEN; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; EPITOPE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; PLASMIN; PROTEINASE; SERINE PROTEINASE; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; BLOOD CLOTTING FACTOR; PHOSPHOLIPID;

ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; DISEASE COURSE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME SPECIFICITY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION; THROMBOGENESIS; THROMBOSIS; VEIN THROMBOSIS; ANTIPHOSPHOLIPID SYNDROME; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIGEN-ANTIBODY REACTIONS; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION FACTORS; FIBRINOLYSIS; HUMANS; PHOSPHOLIPIDS; SERINE ENDOPEPTIDASES; THROMBOSIS;

EID: 59649091253     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308092805     Document Type: Review

References (49)

1. Dahlback B. Blood Coagulation. Lancet 2000; 355: 1627-1632.
2. Esmon CT. Regulation of Blood Coagulation. Biochim Biophys Acta 2000; 1477: 349-360.
3. Walker ID. Congenital thrombophilia. Baillieres Clin Obstet Gynaecol 1997; 11: 431-445.
4. Bick RL Kaplan H. Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Causes of Thrombosis. Med Clin North Am 1998; 82: 409-458.
5. Booth NA. Fibrinolysis and thrombosis. Baillieres Best Pract Res Clin Haematol 1999; 12: 423-433.
6. Juhan-Vague I Valadier J Alessi M. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost 1987; 57: 67-72.
7. Bugge T Flick M Daugherty C Degen J. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 1995; 9: 794-807.
8. Pierangeli SS Chen PP Gonzalez EB. Antiphospholipid antibodies and the antiphospholipid syndrome: An update on treatment and pathogenic mechanisms. Curr Opin Hematol 2006; 13: 366-375.
9. Fleck RA Rapaport SI Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-519.
10. McNeil HP Simpson RJ Chesterman CN Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990; 87: 4120-4124.
11. Oosting JD Derksen RHWM Bobbink IWG Hackeng TM Bouma BN de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism. Blood 1993; 81: 2618-2625.
12. Branch DW Dudley DJ Mitchell MD. Immunoglobulin G fractions from patients with antiphospholipid antibodies caused fetal death in Balb/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163: 210-216.
13. Pierangeli SS Colden-Stanfield M Liu XW Barker JH Anderson GL Harris EN. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999; 99: 1997-2002.
14. Meroni PL Raschi E Testoni C Borghi MO. Endothelial cell activation by antiphospholipid antibodies. Clin Immunol 2004; 112: 169-174.
15. Robertson B Greaves M. Antiphospholipid syndrome: An evolving story. Blood Rev 2006; 20: 201-212.
16. Cariou R Tobelem G Bellucci S. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells-inhibition of thrombomodulin-dependent protein C activation. Thromb Haemost 1988; 60: 54-58.
17. Marciniak E Romond EH. Impaired catalytic function of activated protein C: A new in vitro manifestation of lupus anticoagulant. Blood 1989; 74: 2426-2432.
18. Malia RG Kitchen S Greaves M Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990; 76: 101-107.
19. Borrell M Sala N de Castellanau C Lopez S Gari M Foncuberta J. Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells. Thromb Haemost 1992; 68: 268-272.
20. 2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies. Arthritis Rheum 1999; 42: 167-174.
21. Escolar G Font J Reverter JC. Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Arterioscler Thromb 1992; 12: 196-200.
22. Campbell AL Pierangeli SS Wellhausen S Harris EN. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemost 1995; 73: 529-534.
23. Vega-Ostertag M Harris EN Pierangeli SS. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. Arthritis Rheum 2004; 50: 2911-2919.
24. Kornberg A Blank M Kaufman S Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 1994; 153: 1328-1332.
25. Simantov R LaSala JM Lo SK. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211-2219.
26. 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997; 40: 551-561.
27. Cuadrado MJ López-Pedrera C Khamashta MA. Thrombosis in primary antiphospholipid syndrome - A pivotal role for monocyte tissue factor expression. Arthritis Rheum 1997; 40: 834-841.
28. Amengual O Atsumi T Khamashta MA Hughes GRV. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998; 79: 276-281.
29. Vega-Ostertag M Casper K Swerlick R Ferrara D Harris EN Pierangeli SS. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 2005; 52: 1545-1554.
30. Chamley LW McKay EJ Pattison NS. Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: A mechanism for thrombosis. Thromb Res 1993; 71: 103-111.
31. Hwang K Grossman J Visvanathan S. et al. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J Immunol 2001; 167: 7192-7198.
32. Holers V Girardi G Mo L. et al. Complement c3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195: 211-220.
33. Pierangeli SS Girardi G Vega-Ostertag M Liu X Espinola RG Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 2005; 52: 2120-2124.
34. Cesarman-Maus G Rios-Luna NP Deora AB. et al. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood 2006; 107: 4375-4382.
35. Olee TW Pierangeli SS Handley HH. et al. A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice. Proc Natl Acad Sci U S A 1996; 93: 8606-8611.
36. Zhu M Olee T Le DT. et al. Characterization of IgG monoclonal anti-cardiolipin/antib2GP1 antibodies from two patients with the anti-phospholipid syndrome reveals three species of antibodies. Br J Haematol 1999; 105: 102-109.
37. Pierangeli SS Liu XW Espinola R. et al. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb Haemost 2000; 84: 388-395.
38. Zhao Y Rumold R Ahmed AE. et al. An IgG anti-prothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times. Arthritis Rheum 1999; 42: 2132-2138.
39. Yang YH Hwang KK FitzGerald J. et al. Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin. J Immunol 2006; 177: 8219-8225.
40. Hwang KK Yang CD Yan W Grossman JM Hahn BH Chen PP. A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C. Arthritis Rheum 2003; 48: 1622-1630.
41. Yang CD Hwang KK Yan W. et al. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin. J Immunol 2004; 172: 5765-5773.
42. Vega-Ostertag M Liu X Kwan-Ki H Chen P Pierangeli S. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells. Br J Haematol 2006; 135: 214-219.
43. Kolev K Gombas J Varadi B. et al. Immunoglobulin g from patients with antiphospholipid syndrome impairs the fibrin dissolution with plasmin. Thromb Haemost 2002; 87: 502-508.
44. Tincani A Spatola L Prati E. et al. The anti-b2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native b2-glycoprotein I and preserved during species' evolution. J Immunol 1996; 157: 5732-5738.
45. Chen XX Gu YY Li SJ. et al. Some plasmin-induced antibodies bind to cardiolipin, display lupus anticoagulant activity and induce fetal loss in mice. J Immunol 2007; 178: 5351-5356.
46. Exner T Rickard KA Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-151.
47. Lu CS Horizon AA Hwang KK. et al. Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum 2005; 52: 4018-4027.
48. Cugno M Cabibbe M Galli M. et al. Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: Evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients. Blood 2004; 103: 2121-2126
49. Lin WS Chen PC Yang CD. et al. Some antiphospholipid antibodies recognize conformational epitopes shared by beta(2)-glycoprotein I and the homologous catalytic domains of several serine proteases. Arthritis Rheum 2007; 56: 1638-1647.